Bausch Health Companies Inc. Business Finance Contracts & Agreements

Second Amendment to Credit and Security Agreement, dated as of March 28, 2024, amending the Credit and Security Agreement, dated June 30, 2023, by and among Bausch Receivables... (Filed With SEC on May 2, 2024)

Stock and Asset Purchase Agreement by and among Buyer, Novartis and, for the limited purposes set forth therein, Bausch + Lomb, dated as of June 30, 2023 (Filed With SEC on July 7, 2023)

Credit and Security Agreement, dated June 30, 2023, by and among Bausch Receivables Funding LP, as Borrower, Bausch Receivables Funding GP ULC, Bausch Health US, LLC, as the... (Filed With SEC on July 7, 2023)

Sixteenth Supplemental Indenture, dated as of September 14, 2022, by and among Bausch Health Americas, Inc. (BHA) and the Bank of New York Mellon, as trustee, amending that... (Filed With SEC on November 3, 2022)

Fourteenth Supplemental Indenture, dated as of September 14, 2022, by and among Bausch Health Companies Inc. and the Bank of New York Mellon, as trustee, amending that certain... (Filed With SEC on November 3, 2022)

Fifteenth Supplemental Indenture, dated as of September 28, 2022, by and among Bausch Health Companies Inc. and the Bank of New York Mellon, as trustee, amending that certain... (Filed With SEC on November 3, 2022)

Sixteenth Supplemental Indenture, dated as of September 14, 2022, by and among Bausch Health Americas, Inc. and the Bank of New York Mellon, as trustee, amending that certain... (Filed With SEC on November 3, 2022)

Indenture, dated as of September 30, 2022, by and among 1375209 B.C. Ltd., The Bank of New York Mellon, as trustee, and The Bank of New York Mellon, as notes collateral agent (Filed With SEC on October 4, 2022)

Indenture, dated as of September 30, 2022, by and among Bausch Health Companies Inc., the guarantors party thereto, The Bank of New York Mellon, as trustee, and the notes... (Filed With SEC on October 4, 2022)

Indenture, dated as of June 8, 2021 by and among Bausch Health Companies Inc., the guarantors party thereto, The Bank of New York Mellon, as trustee and the notes collateral... (Filed With SEC on June 8, 2021)

Indenture, dated as of December 3, 2020, by and among Bausch Health Companies Inc., the guarantors party thereto and The Bank of New York Mellon, as trustee (Filed With SEC on December 3, 2020)

Indenture, dated as of May 26, 2020, by and among Bausch Health Companies Inc., the guarantors party thereto and The Bank of New York Mellon, as trustee (Filed With SEC on May 26, 2020)

Indenture, dated as of December 30, 2019, by and among Bausch Health Companies Inc., the guarantors party thereto and The Bank of New York Mellon, as trustee (Filed With SEC on December 30, 2019)

Indenture, dated as of May 23, 2019, by and among Bausch Health Companies Inc., the guarantors party thereto and The Bank of New York Mellon, as trustee (Filed With SEC on May 24, 2019)

Amended and Restated Asset Purchase Agreement dated January 4, 2019 among Bausch Health Companies Inc., Bausch Health Ireland Limited, Synergy Pharmaceuticals Inc. and Synergy... (Filed With SEC on February 20, 2019)

Form of Common Share Certificate of Bausch Health Companies Inc (Filed With SEC on July 16, 2018)

Indenture, dated as of June 1, 2018, by and among Valeant Pharmaceuticals International, Valeant Pharmaceuticals International, Inc., the other guarantors party thereto and The... (Filed With SEC on June 1, 2018)

Indenture, dated as of December 18, 2017, by and among Valeant Pharmaceuticals International, Inc., the guarantors party thereto and The Bank of New York Mellon, as trustee (Filed With SEC on December 18, 2017)

General Waiver & Release (Filed With SEC on February 2, 2016)

JOINDER AGREEMENT (Filed With SEC on April 30, 2015)

SUPPLEMENTAL INDENTURE RELATED TOTHE ASSUMPTION (Filed With SEC on March 27, 2015)

VRX ESCROW CORP. $2,000,000,000 5.375% SENIOR NOTES DUE 2020 $3,250,000,000 5.875% SENIOR NOTES DUE 2023 1,500,000,000 4.50% SENIOR NOTES DUE 2023 $3,250,000,000 6.125% SENIOR... (Filed With SEC on March 27, 2015)

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. $1,450,000,000 of Common Shares Underwriting Agreement (Filed With SEC on March 18, 2015)

JOINDER AGREEMENT (Filed With SEC on February 25, 2015)

SUCCESSOR AGENT AGREEMENT AND AMENDMENT NO. 9 TO THIRD AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT (Filed With SEC on February 25, 2015)

VALEANT PHARMACEUTICALSINTERNATIONAL, INC. 5.50% SENIOR NOTES DUE 2023 INDENTURE DATED AS OFJANUARY 30, 2015 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE TABLE OF... (Filed With SEC on January 30, 2015)

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. 5.625% SENIOR NOTES DUE 2021 INDENTURE DATED AS OF DECEMBER 2, 2013 THE BANK OFNEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE TABLE OF... (Filed With SEC on December 2, 2013)

FIFTEENTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

FOURTEENTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

THIRTEENTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

TENTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

NINTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

FOURTEENTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

THIRTEENTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

TWELFTH SUPPLEMENTAL INDENTURE (Filed With SEC on November 1, 2013)

Category

Industry

Companies

Contracts

Bausch Health Companies Inc. Business Finance Contracts & Agreements